UNSPSC 51343107: Fiacitabine

This classification denotes a pyrimidine antagonist and antiviral agent with the molecular formula C9H11FIN3O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 4058H365ZB, chemically known as 2(1h)-pyrimidinone, 4-amino-1-(2-deoxy-2-fluoro-beta-d-arabinofuranosyl)-5-iodo- but generally known as fiacitabine, which bears US NIH Compound Identifier 50312. European Medicines Agency schedules Fiacitabine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07621MIG.

UNSPSC 51343107 Fiacitabine is a Commodity code that nominally refers to a specific pharmaceutical active ingredient, but the recent state and local procurement activity tagged under it encompasses a much broader range of pharmaceutical and medical supply procurement — including naloxone and drug deactivation systems, generic multi-source pharmaceuticals and over-the-counter products, medical and first aid supplies for emergency response, and therapeutic pharmacy initiatives. State and local issuers soliciting under this code span county health departments, state health and human services agencies, municipal fire departments, and multistate cooperative purchasing alliances. The work being bought includes both direct procurement of finished pharmaceutical products and the establishment of vendor-managed supply frameworks that route products through authorized wholesalers to multiple jurisdictions and agencies simultaneously.

Recent opportunities show activity across multiple states and purchasing vehicles. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, issued RFP S1070000015802 on January 20, 2026 (response deadline March 26, 2026) seeking manufacturers of generic multi-source pharmaceuticals and OTC products for distribution across participating state and local government facilities including Oregon. Seminole County, Florida issued IFB 60459723LAS on June 30, 2026 (response deadline July 26, 2023) to procure 1,900 units of naloxone and 800 safe drug deactivation systems annually for the County Community Health Building. The City of Tampa issued ITB 26P00145 on March 25, 2026 (response deadline March 13, 2026) for 169 line items of medical and first aid supplies for the Tampa Fire Department Rescue Division, designated as a sheltered market opportunity for certified Small Local Business Enterprises with a 5 percent bid discount not to exceed $10,000 and an estimated contract amount of $700,000.00. The Texas Health and Human Services Commission issued RFI HHS0017013 on April 3, 2026 to gather vendor capabilities regarding direct-to-manufacturer prescription programs outside traditional pharmacy benefit manager and group purchasing organization channels. Geographic spread centers on Florida and Texas, with multistate cooperative activity anchored in Minnesota.